drugset / Trial / NCT00312481

MOVIPREP® Versus PICOLAX® Pilot Study

NCT00312481

Phase 2 Completed 65 enrolled Norgine
RandomizedParallel-groupDouble-blindTreatment

Summary

This will be a randomised, single-centre, single-blind, parallel-group, pilot study in patients undergoing colonoscopy. The primary objective is to evaluate the efficacy of MOVIPREP® versus PICOLAX® for gut cleansing prior to colonoscopy. The secondary objectives are to evaluate the safety, tolerability and acceptability of MOVIPREP versus PICOLAX for gut cleansing prior to colonoscopy.

Timeline

Start
2005-07
Primary completion
Completion
2006-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Moviprep Other / unclassified 1000 ml
Comparator NA picosulfate magnesium citrate Unknown 150 ml

Indications

No indication recorded.